Adagene Inc. American Depositary Shares (ADAG) Stock Price

ADAGStock

$2.06+15.73%52W

Market Cap$138.32M

P/E—

PEG Ratio—

Div yield—

Beta0.66

ADAG Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-55.84%

Price vs S&P 500 (4W)-34.50%

VGM Score60.75

Book Value / Share (Quarterly)$1.26

P/TBV (Annual)0.76x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-6.18%

Cash Flow / Share (Quarterly)$-0.23

Price vs S&P 500 (YTD)-2.93%

Net Profit Margin (TTM)-220.77%

EPS (TTM)$-0.30

10-Day Avg Trading Volume0.49M

EPS Excl Extra (TTM)$-0.30

Revenue Growth (5Y)61.42%

EPS (Annual)$-0.30

ROI (Annual)-30.35%

Net Profit Margin (5Y Avg)-6860.31%

Cash / Share (Quarterly)$1.52

Revenue Growth QoQ (YoY)7333.04%

ROA (Last FY)-22.50%

Revenue Growth TTM (YoY)8902.72%

EBITD / Share (TTM)$-0.34

ROE (5Y Avg)-53.98%

Operating Margin (TTM)-240.42%

Cash Flow / Share (Annual)$-0.26

P/B Ratio1.52x

P/B Ratio (Quarterly)2.62x

Net Income / Employee (Annual)$-137,600

EV / Revenue (TTM)4.19x

Net Interest Coverage (TTM)-79.31x

ROA (TTM)-19.36%

EPS Incl Extra (Annual)$-0.30

Current Ratio (Annual)3.07x

Quick Ratio (Quarterly)5.00x

3-Month Avg Trading Volume0.30M

52-Week Price Return15.73%

Revenue / Employee (TTM)$72,600

Tangible BV / Share (Quarterly)$1.92

P/S Ratio (Annual)21.01x

Asset Turnover (Annual)0.10x

52-Week High$4.85

Operating Margin (5Y Avg)-7372.27%

EPS Excl Extra (Annual)$-0.30

CapEx CAGR (5Y)-55.15%

26-Week Price Return-45.93%

Quick Ratio (Annual)3.06x

13-Week Price Return-42.62%

Total Debt / Equity (Annual)0.12x

Current Ratio (Quarterly)5.02x

Enterprise Value$38.96M

Revenue / Share Growth (5Y)52.04%

Asset Turnover (TTM)0.09x

Revenue / Employee (Annual)$59,900

Pretax Margin (Annual)-233.44%

Cash / Share (Annual)$1.26

3-Month Return Std Dev77.74%

Net Income / Employee (TTM)$-160,200

ROE (Last FY)-33.93%

EPS Basic Excl Extra (Annual)$-0.30

Receivables Turnover (TTM)6.20x

Total Debt / Equity (Quarterly)0.05x

EPS Incl Extra (TTM)$-0.30

Receivables Turnover (Annual)6.19x

ROI (TTM)-24.17%

P/S Ratio (TTM)17.34x

Pretax Margin (5Y Avg)-6858.29%

Revenue / Share (Annual)$0.13

Tangible BV / Share (Annual)$1.92

Price vs S&P 500 (52W)0.20%

Year-to-Date Return8.99%

5-Day Price Return-24.82%

EPS Normalized (Annual)$-0.30

ROA (5Y Avg)-33.48%

Net Profit Margin (Annual)-229.56%

Month-to-Date Return-35.63%

EBITD / Share (Annual)$-0.36

Operating Margin (Annual)-279.48%

LT Debt / Equity (Annual)0.02x

ROI (5Y Avg)-43.23%

LT Debt / Equity (Quarterly)0.01x

EPS Basic Excl Extra (TTM)$-0.30

P/TBV (Quarterly)0.76x

P/B Ratio (Annual)1.65x

Pretax Margin (TTM)-224.71%

Book Value / Share (Annual)$0.88

Price vs S&P 500 (13W)-45.30%

Beta0.66x

Revenue / Share (TTM)$0.13

ROE (TTM)-25.98%

52-Week Low$1.30

vGradeC

gGradeA

mGradeD

vgmGradeB

ADAG Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.17

4.15

4.17

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
ADAGAdagene Inc. American Depositary Shares	C	A	D	17.3x	8902.7%	—	—	$2.06
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Adagene Inc. American Depositary Shares

Adagene is a clinical-stage biopharmaceutical company developing monoclonal antibody immunotherapies for cancer treatment. The company's proprietary platform generates therapeutic antibody candidates with enhanced functional epitopes and species cross-reactivity, enabling a differentiated pipeline of cancer immunotherapy programs.

ADAG Insider Transactions

BuyAug 14, 2026
DO CUONG VIET
Director
Shares: 2,000Value: $7,500

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

DTILPrecision BioSciences, Inc. Common StockBiological Products
CMPXCompass Therapeutics, Inc. Common StockBiological Products
MDWDMediWound Ltd.Pharmaceutical Preparations
CHRSCoherus Oncology, Inc. Common StockBiological Products
NNNNAnbio Biotechnology Class A Ordinary SharesIn Vitro Diagnostics
TARAProtara Therapeutics, Inc. Common StockBiological Products
MOLNMolecular Partners AG American Depositary SharesBiological Products
LODEComstock Inc.Industrial Chemicals

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Buy

Consensus rating

52-Week Range

Low$1.30

High$4.85